g-Protein Coupled Receptor Family C, Group 5, Member A (gprc5a) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic Obstructive Pulmonary Disease and Non–Small-Cell Lung Cancer

Introduction: Understanding oncogenes and tumor suppressor genes expression patterns is essential for characterizing lung cancer pathogenesis. We have previously demonstrated that mGprc5a/hGPRC5A is a lung-specific tumor suppressor evidenced by inflammation-mediated tumorigenesis in Gprc5a-knockout mice. The implication of GPRC5A in human lung cancer pathogenesis, including that associated with inflammatory chronic obstructive pulmonary disease (COPD), a risk factor for the malignancy, remains elusive. Methods: We sought to examine GPRC5A immunohistochemical expression in histologically normal bronchial epithelia (NBE) from lung disease-free never- and ever-smokers (n = 13 and n = 18, respectively), from COPD patients with (n = 26) and without cancer (n = 24) and in non-small cell lung cancers (NSCLCs) (n = 474). Quantitative assessment of GPRC5A transcript expression in airways (n = 6), adjacent NBEs (n = 29) and corresponding tumors (n = 6) from 6 NSCLC patients was also performed. Results: GPRC5A immunohistochemical expression was significantly lower in tumors compared to uninvolved NBE (p < 0.0001) and was positively associated with adenocarcinoma histology (p < 0.001). GPRC5A airway expression was highest in lung disease-free NBE, decreased and intermediate in NBE of cancer-free COPD patients (p = 0.004) and further attenuated and lowest in epithelia of COPD patients with adenocarcinoma and SCC (p < 0.0001). Furthermore, GPRC5A mRNA was significantly decreased in NSCLCs and corre sponding NBE compared to uninvolved normal lung (p = 0.03). Conclusions: Our findings highlight decreased GPRC5A expression in the field cancerization of NSCLC, including that associated with lung inflammation. Assessment of the use of GPRC5A expression as a risk factor for NSCLC development in COPD patients is warranted.

[1]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[2]  R. Lotan,et al.  Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation , 2012, Molecular Cancer.

[3]  A. Blom,et al.  Haemophilus influenzae protein E binds to the extracellular matrix by concurrently interacting with laminin and vitronectin. , 2011, The Journal of infectious diseases.

[4]  Edward S. Kim,et al.  The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration , 2011, Cancer Prevention Research.

[5]  C. Rooney,et al.  The Epithelial Cell and Lung Cancer: The Link between Chronic Obstructive Pulmonary Disease and Lung Cancer , 2011, Respiration.

[6]  R. Lotan,et al.  Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout Mice , 2010, PloS one.

[7]  R. Lotan,et al.  Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis , 2010, Cancer Prevention Research.

[8]  Carmen Behrens,et al.  HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors , 2009, Clinical Cancer Research.

[9]  Gina Lee,et al.  Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer , 2009, Current opinion in pulmonary medicine.

[10]  R. Lotan,et al.  Mechanisms underlying the induction of the putative human tumor suppressor GPRC5A by Retinoic acid , 2009, Cancer biology & therapy.

[11]  M. Hind,et al.  Retinoid induction of alveolar regeneration: from mice to man? , 2009, Thorax.

[12]  R. Lotan,et al.  Activation of Protein Kinase C by Phorbol 12-Myristate 13-Acetate suppresses the growth of lung cancer cells through KLF6 induction , 2009, Cancer biology & therapy.

[13]  E. Szabo,et al.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. , 2009, Journal of the National Cancer Institute.

[14]  Avrum Spira,et al.  The Field of Tissue Injury in the Lung and Airway , 2008, Cancer Prevention Research.

[15]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[16]  E. Engels.  Inflammation in the development of lung cancer: epidemiological evidence , 2008, Expert review of anticancer therapy.

[17]  R. Lotan,et al.  Identification of the Retinoic Acid – Inducible Gprc5a as a New Lung Tumor Suppressor Gene , 2022 .

[18]  M. Thun,et al.  Lung cancer, smoke exposure, and sex. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Beebe-Dimmer,et al.  Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia , 2006, CA: a cancer journal for clinicians.

[20]  I. Wistuba,et al.  Lung cancer preneoplasia. , 2006, Annual review of pathology.

[21]  A. Schwartz,et al.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[22]  D. Mannino,et al.  Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. , 2003, Archives of internal medicine.

[23]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[24]  D. Mannino.  COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[25]  S. Lippman,et al.  Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. , 1999, Journal of the National Cancer Institute.

[26]  S. Lam,et al.  Sex-related differences in bronchial epithelial changes associated with tobacco smoking. , 1999, Journal of the National Cancer Institute.

[27]  R. Lotan,et al.  Molecular Cloning and Characterization of a Novel Retinoic Acid-inducible Gene That Encodes a Putative G Protein-coupled Receptor* , 1998, The Journal of Biological Chemistry.

[28]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[29]  R. Lotan,et al.  Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. , 1997, Journal of the National Cancer Institute.

[30]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[31]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[32]  H. David,et al.  Rudolf Virchow and modern aspects of tumor pathology. , 1988, Pathology, research and practice.

[33]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[34]  B. Cohen.  COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1978, The Lancet.

[35]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[36]  A. Aromaa,et al.  Letter: Mortality and anaemia. , 1974, Lancet.

[37]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. , 1961, The New England journal of medicine.